{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T14:09:00Z","timestamp":1790345340068,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T00:00:00Z","timestamp":1525219200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Qual Life Outcomes"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12955-018-0908-9","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T08:42:05Z","timestamp":1525250525000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":117,"title":["The impact of severe haemophilia and the presence of target joints on health-related quality-of-life"],"prefix":"10.1186","volume":"16","author":[{"given":"Jamie","family":"O\u2019Hara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaun","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Camp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Mazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liz","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Hoxer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,2]]},"reference":[{"key":"908_CR1","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.1365-2516.2006.01263.x","volume":"12","author":"F Peyvandi","year":"2006","unstructured":"Peyvandi F, Jayandharan G, Chandy M, Srivastava A, Nakaya SM, Johnson MJ, et al. Genetic diagnosis of haemophilia and other inherited bleeding disorders. Haemophilia. 2006;12:82\u20139.","journal-title":"Haemophilia"},{"key":"908_CR2","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.mjafi.2011.12.007","volume":"68","author":"J Philip","year":"2012","unstructured":"Philip J, Sarkar RS, Kumar S, Prathip BR, Pathak A. Factor IX deficiency (Christmas disease). Med J Armed Forces India. 2012;68:379\u201380.","journal-title":"Med J Armed Forces India"},{"key":"908_CR3","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/j.1365-2516.2006.01397.x","volume":"13","author":"CK Kasper","year":"2007","unstructured":"Kasper CK, Lin JC. Prevalence of sporadic and familial haemophilia. Haemophilia. 2007;13:90\u20132.","journal-title":"Haemophilia"},{"key":"908_CR4","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2147\/JBM.S50644","volume":"5","author":"S Lobet","year":"2014","unstructured":"Lobet S, Hermans C, Lambert C. Optimal management of hemophilic arthropathy and hematomas. J Blood Med Dove Press. 2014;5:207\u201318.","journal-title":"J Blood Med Dove Press"},{"key":"908_CR5","unstructured":"World Federation of Hemophilia. Guidelines for the Management of Hemophilia [Internet]. 2012. Available from: \n                    https:\/\/www1.wfh.org\/publication\/files\/pdf-1472.pdf\n                    \n                  ."},{"issue":"Suppl 4","key":"908_CR6","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/j.1365-2516.2004.00976.x","volume":"10","author":"K Mulder","year":"2004","unstructured":"Mulder K, Llin\u00e1s A. The target joint. Haemophilia. 2004;10(Suppl 4):152\u20136.","journal-title":"Haemophilia"},{"key":"908_CR7","doi-asserted-by":"publisher","first-page":"S360","DOI":"10.1016\/j.amepre.2011.09.017","volume":"41","author":"PE Monahan","year":"2011","unstructured":"Monahan PE, Baker JR, Riske B, Soucie JM. Physical functioning in boys with hemophilia in the U.S. Am J Prev Med. 2011;41:S360\u20138.","journal-title":"Am J Prev Med"},{"key":"908_CR8","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1111\/hae.12108","volume":"19","author":"M Bladen","year":"2013","unstructured":"Bladen M, Main E, Hubert N, Koutoumanou E, Liesner R, Khair K. Factors affecting the Haemophilia joint health score in children with severe haemophilia. Haemophilia. 2013;19:626\u201331.","journal-title":"Haemophilia"},{"key":"908_CR9","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/j.1365-2516.2010.02400.x","volume":"17","author":"JM Soucie","year":"2011","unstructured":"Soucie JM, Wang C, Siddiqi A, Kulkarni R, Recht M, Konkle BA, et al. The longitudinal effect of body adiposity on joint mobility in young males with Haemophilia a. Haemophilia. 2011;17:196\u2013203.","journal-title":"Haemophilia"},{"key":"908_CR10","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1182\/blood-2016-02-683169","volume":"129","author":"MJ Manco-Johnson","year":"2017","unstructured":"Manco-Johnson MJ, Soucie JM, Gill JC. Prophylaxis usage, bleeding rates and joint outcomes of hemophilia 1999 - 2010: a surveillance project. Blood. 2017;129:2368\u201375.","journal-title":"Blood"},{"key":"908_CR11","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/ejh.12433","volume":"94","author":"E Santagostino","year":"2015","unstructured":"Santagostino E, Auerswald G, Benson G, Dolan G, Jim\u00e9nez-Yuste V, Lambert T, et al. Switching treatments in haemophilia: is there a risk of inhibitor development. Eur J Haematol. 2015;94:284\u20139. Wiley-Blackwell","journal-title":"Eur J Haematol"},{"key":"908_CR12","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1046\/j.1365-2516.2003.00849.x","volume":"10","author":"RLRL Bohn","year":"2004","unstructured":"Bohn RLRL, Aledort LM, Putnam K, Ewenstein B, Mogun H, Avorn JJ. The economic impact of factor VIII inhibitors in patients with haemophilia. Haemophilia. 2004;10:63\u20138.","journal-title":"Haemophilia"},{"key":"908_CR13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1365-2516.2010.02280.x","volume":"17","author":"A Coppola","year":"2011","unstructured":"Coppola A, Cerbone AM, Mancuso G, Mansueto MF, Mazzini C, Zanon E. Confronting the psychological burden of haemophilia. Haemophilia. 2011;17:21\u20137.","journal-title":"Haemophilia"},{"issue":"Suppl 3","key":"908_CR14","first-page":"s567","volume":"12","author":"Y Kodra","year":"2014","unstructured":"Kodra Y, Cavazza M, Schieppati A, De Santis M, Armeni P, Arcieri R, et al. The social burden and quality of life of patients with haemophilia in Italy. Blood Transfus. 2014;12(Suppl 3):s567\u201375. SIMTI Servizi","journal-title":"Blood Transfus"},{"key":"908_CR15","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/j.1365-2516.2010.02435.x","volume":"17","author":"R Klamroth","year":"2011","unstructured":"Klamroth R, Pollmann H, Hermans C, Faradji A, Yarlas AS, Epstein JD, et al. The relative burden of haemophilia a and the impact of target joint development on health-related quality of life: results from the ADVATE post-authorization safety surveillance (PASS) study. Haemophilia. 2011;17:412\u201321.","journal-title":"Haemophilia"},{"key":"908_CR16","unstructured":"Camp C, Carroll L, Hughes D, Burke T, OHara J. An Introduction to \u201c The Cost of Haemophilia across Europe \u2013 a Socioeconomic Survey \u201d (CHESS). Poster presented at WFH 2016 World Congress."},{"issue":"Suppl 1","key":"908_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1365-2516.2005.01153.x","volume":"11","author":"C Knight","year":"2005","unstructured":"Knight C. Health economics of treating haemophilia a with inhibitors. Haemophilia. 2005;11(Suppl 1):11\u20137.","journal-title":"Haemophilia"},{"key":"908_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/med\/9780198725923.001.0001","volume-title":"Measuring and valuing health benefits for economic evaluation. Second","author":"J Brazier","year":"2016","unstructured":"Brazier J, Ratcliffe J, Tsuchiya A, Salomon J. Measuring and valuing health benefits for economic evaluation. Second. Oxford: Oxford University Press; 2016."},{"key":"908_CR19","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1007\/s00125-002-0861-2","volume":"45","author":"M Koopmanschap","year":"2002","unstructured":"Koopmanschap M. Coping with type II diabetes: the patient\u2019s perspective. Diabetologia. 2002;45:S18\u201322.","journal-title":"Diabetologia"},{"key":"908_CR20","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1111\/j.1538-7836.2007.02663.x","volume":"5","author":"BA Konkle","year":"2007","unstructured":"Konkle BA, Ebbesen LS, Erhardtsen E, Bianco RP, Lissitchkov T, Rusen L, et al. Randomized, prospective clinical trial of recombinant factor VIIa for secondary prophylaxis in hemophilia patients with inhibitors. J Thromb Haemost. 2007;5:1904\u201313. Blackwell Publishing Ltd","journal-title":"J Thromb Haemost"},{"key":"908_CR21","doi-asserted-by":"crossref","unstructured":"Glick HA, Doshi JA, Sonnad SS, Polsky D. Economic evaluation in clinical trials. Oxford: Oxford University Press; 2014.","DOI":"10.1093\/med\/9780199685028.001.0001"},{"key":"908_CR22","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1002\/hec.1653","volume":"20","author":"B Mihaylova","year":"2011","unstructured":"Mihaylova B, Briggs A, O\u2019Hagan A, Thompson SG. Review of statistical methods for analysing healthcare resources and costs. Health Econ. 2011;20:897\u2013916.","journal-title":"Health Econ"},{"key":"908_CR23","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jval.2013.10.004","volume":"17","author":"D Coughlan","year":"2014","unstructured":"Coughlan D, Yeh ST, Neill CO, Frick KD. Evaluating direct medical expenditures estimation methods of adults using the medical expenditure panel Survey\u00a0: an example focusing on head and neck cancer. Value Heal. 2014;17:90\u20137. Elsevier","journal-title":"Value Heal"},{"key":"908_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/0470856289","volume-title":"Statistical analysis of cost-effectiveness data","author":"A Willan","year":"2006","unstructured":"Willan A, Briggs A. Statistical analysis of cost-effectiveness data. Chichester: John Wiley & Sons Ltd; 2006."},{"key":"908_CR25","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0167-6296(01)00086-8","volume":"20","author":"WG Manning","year":"2001","unstructured":"Manning WG, Mullahy J. Estimating log models: to transform or not to transform? J Health Econ. 2001;20:461\u201394.","journal-title":"J Health Econ"},{"key":"908_CR26","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12955-016-0537-0","volume":"14","author":"N McCaffrey","year":"2016","unstructured":"McCaffrey N, Kaambwa B, Currow DC, Ratcliffe J. Health-related quality of life measured using the EQ-5D\u20135L: south Australian population norms. Heal Qual Life Outcomes. 2016;14:133.","journal-title":"Heal Qual Life Outcomes"},{"key":"908_CR27","unstructured":"StataCorp. 2013. Stata Statistical Software: Release 13. College Station, TX: StataCorp LP. \n                    https:\/\/www.stata.com\/support\/faqs\/resources\/citing-software-documentation-faqs\/\n                    \n                  ."},{"key":"908_CR28","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1046\/j.1365-2516.2002.00581.x","volume":"8","author":"S Royal","year":"2002","unstructured":"Royal S, Schramm W, Berntorp E, Giangrande P, Gringeri A, Ludlam C, et al. Quality-of-life differences between prophylactic and on-demand factor replacement therapy in European haemophilia patients. Haemophilia. 2002;8:44\u201350.","journal-title":"Haemophilia"},{"key":"908_CR29","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2147\/VHRM.S5217","volume":"6","author":"HC Rossbach","year":"2010","unstructured":"Rossbach HC. Review of antihemophilic factor injection for the routine prophylaxis of bleeding episodes and risk of joint damage in severe hemophilia a. Vasc Health Risk Manag. 2010;6:59\u201368.","journal-title":"Vasc Health Risk Manag"},{"key":"908_CR30","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1111\/j.1538-7836.2008.02929.x","volume":"6","author":"M Walsh","year":"2008","unstructured":"Walsh M, Macgregor D, Stuckless S, Barrett B, Kawaja M, Scully M-F. Health-related quality of life in a cohort of adult patients with mild hemophilia a. J Thromb Haemost. 2008;6:755\u201361.","journal-title":"J Thromb Haemost"},{"key":"908_CR31","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1111\/j.1538-7836.2009.03318.x","volume":"7","author":"SM Siboni","year":"2009","unstructured":"Siboni SM, Mannucci PM, Gringeri A, Franchini M, Tagliaferri A, Ferretti M, et al. Health status and quality of life of elderly persons with severe hemophilia born before the advent of modern replacement therapy. J Thromb Haemost. 2009;7:780\u20136.","journal-title":"J Thromb Haemost"},{"key":"908_CR32","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1111\/jth.12672","volume":"12","author":"VS Blanchette","year":"2014","unstructured":"Blanchette VS, Key NS, Ljung LR, Manco-Johnson MJ, van den Berg HM, Srivastava A, et al. Definitions in hemophilia: communication from the SSC of the ISTH. J Thromb Haemost. 2014;12:1935\u20139.","journal-title":"J Thromb Haemost"},{"key":"908_CR33","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/j.1365-2516.2007.01535.x","volume":"13","author":"NJ Goddard","year":"2007","unstructured":"Goddard NJ, Mann H. Diagnosis of haemophilic synovitis. Haemophilia. 2007;13:14\u20139.","journal-title":"Haemophilia"},{"key":"908_CR34","first-page":"1","volume":"8","author":"J O\u2019Hara","year":"2018","unstructured":"O\u2019Hara J, Walsh S, Camp C, Mazza G, Carroll L, Hoxer C, et al. The relationship between target joints and direct resource use in severe haemophilia. Health. Econ Rev. 2018;8:1. SpringerOpen","journal-title":"Econ Rev"},{"issue":"Suppl 1","key":"908_CR35","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1046\/j.1365-2516.9.s1.13.x","volume":"9","author":"K Fischer","year":"2003","unstructured":"Fischer K, van der Bom JG, van den Berg HM. Health-related quality of life as outcome parameter in haemophilia treatment. Haemophilia. 2003;9(Suppl 1):75\u201381. discussion 82","journal-title":"Haemophilia"},{"key":"908_CR36","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/1477-7525-12-74","volume":"12","author":"CB Agborsangaya","year":"2014","unstructured":"Agborsangaya CB, Lahtinen M, Cooke T, Johnson JA. Comparing the EQ-5D 3L and 5L: measurement properties and association with chronic conditions and multimorbidity in the general population. Health Qual Life Outcomes. 2014;12:74.","journal-title":"Health Qual Life Outcomes"}],"container-title":["Health and Quality of Life Outcomes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12955-018-0908-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12955-018-0908-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12955-018-0908-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T19:15:09Z","timestamp":1556738109000},"score":1,"resource":{"primary":{"URL":"https:\/\/hqlo.biomedcentral.com\/articles\/10.1186\/s12955-018-0908-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,2]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["908"],"URL":"https:\/\/doi.org\/10.1186\/s12955-018-0908-9","relation":{},"ISSN":["1477-7525"],"issn-type":[{"value":"1477-7525","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,2]]},"assertion":[{"value":"16 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The CHESS study was reviewed by the Research Ethics Sub Committee of the Faculty of Health and Social Care within the University of Chester. Patient consent for use of clinical data was not required (as per European Pharmaceutical Market Research Association (EPhMRA) guidelines). Patient consent was obtained via tick box selection for the PSC element of the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"LW and CH are employees of Novo Nordisk.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"84"}}